GenAssist pitches at 9th Annual Crab Trap Pitch Competition
Joe Beggs delivers pitch at the BioHealth Capital Region Investment Conference in Rockville, MD
September 19, 2024
GenAssist selected for Inaugural Frontier BioHealth Program by Activation Capital
One of Ten innovative life sciences and healthtech companies chosen for 16-week accelerator
August 28, 2024
GenAssist pitches at SLU New Venture Accelerator Demo Day
Gabe Haas delivers pitch to a room full of investors, strategic partners, and St. Louis ecosystem leaders
August 1, 2024
GenAssist completes Second Round of the National I-Corps Program
Team completes an additional 100+ customer interviews, bringing the total to over 200
May 7, 2024
GenAssist selected for the Inaugural SLU New Venture Accelerator Cohort
Includes an equity-free investment of up to $50,000
April 18, 2024
As part of the SLU New Venture Accelerator’s first-ever cohort, GenAssist will have access to high-level business coaching from the Chaifetz Center for Entrepreneurship. This 14-week program will focus on customer discovery, validation, business development, revenue modeling, and more. The program will culminate with a Demo Day where GenAssist will pitch to and meet with investors, strategic partners, and other community leaders.
GenAssist selected as Finalist for M2D2’s 200k Challenge
Won a $20,000 of in-kind services from Hologic
March 27, 2024
In March 2024, the GenAssist Team traveled to Lowel, MA, and pitched MyoGel for its applications in Women’s health in front of a crowd of at least 200 people. GenAssist was awarded $20,000 worth of in-kind services from Hologic, a leading company in Women’s health.
GenAssist’s Patent Granted by the United States Patent and Trademark Office
Recognition of Innovation and Uniqueness Protects Core Technology
September 5, 2023
GenAssist Awarded Competitive Grant from the U.S. National Science Foundation
R&D funding accelerates the translation of results to impact
May 1, 2023